The expanded MDSCs enhance the differentiation of naive CD4+ T-cell precursors into Th17 cells and are positively correlated with disease severity of SLE and RA patients as well as their murine models [12–15]. This evidence concerns the gene CD4 and systemic lupus erythematosus.